title: Rheumatoid arthritis patients with therapy-induced myelodysplastic syndrome present with long-term remission after recovery.
authors.forename: R
authors.initials: R
authors.lastname: Thonhofer
authors.forename: M
authors.initials: M
authors.lastname: Kriessmayr
authors.forename: U
authors.initials: U
authors.lastname: Thonhofer
authors.forename: E
authors.initials: E
authors.lastname: Wipfler
authors.forename: E
authors.initials: E
authors.lastname: Uitz
authors.forename: B
authors.initials: B
authors.lastname: Bahadori
authors.forename: S
authors.initials: S
authors.lastname: Eder
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D004177:Dipyrone / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000276:immunology*; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D007555:Isoxazoles; D004177:Dipyrone; D000077339:Leflunomide; D008727:Methotrexate